Retinalamin
Price and cost-per-mg comparison
Retinalamin is a polypeptide bioregulator preparation derived from retinal tissue, classified as a Khavinson-class agent investigated for neuroprotective and anti-aging effects in photoreceptors and retinal ganglion cells, proposed to support visual function by modulating gene expression and cellular homeostasis in aging retinal tissue. Like other Khavinson bioregulator preparations, retinalamin is proposed to exert tissue-specific regulatory effects through intracellular transport of ultrashort active peptide components via amino acid carrier mechanisms, modulating transcriptional activity in retinal pigment epithelium and photoreceptor cells under degenerative or age-related stress conditions. Published research on Khavinson-class ultrashort peptides has characterized intracellular transport mechanisms via POT and LAT carriers and neuroepigenetic regulatory actions in aging neural tissue, providing the class-level mechanistic framework within which retinalamin's retinal effects are proposed. Retinalamin has no FDA approval; it is used as a clinical preparation in Russia and Eastern Europe for degenerative retinal conditions, and its evidence base derives from Russian-origin preclinical and observational studies that have not been independently replicated in Western-indexed clinical literature.
Learn more ↗Compare listings
Filter by vial size and quantity — the figures and table follow.
| Vendor | Size | Price | Cost per mg▲ | COA | Source | Availability | Actions |
|---|---|---|---|---|---|---|---|
Other sizessingle vials, one listing each1 listing | |||||||
US Retinalamin | 10 mg vial | $45.48 | $4.55 | — | Vendor feed · 2 wk ago | In stock | View ↗ |
10 × 5 mg10-vial packs1 listing | |||||||
CA Retinalamin — 10 × 5mg | Retinal Peptide Complex | 10 × 5 mg50 mg total | $287.99$28.80 / viallisted CAD 399.99 | $5.76 | Vendor feed · 2 wk ago | In stock | View ↗ | |
— in COA: no certificate on file for this vendor— in availability: stock not read at the last checkPrices as scraped; foreign prices converted to USD
When Retinalamin prices moved
0 days in the last 120 on which a feed run read comparable Retinalamin prices from 3 or more vendors. Each point is the median $/mg across every comparable listing read that day, sized by how many vendors were read. A log of run days, not a continuous series.
How these prices are computed
The short version. The methodology page has the rest.
Source
Prices are read from each vendor's own store feed or product markup (Vendor feed). Every row says which source it came from and when it was read. Prices parsed from page text are not in this index.
$/mg
Listed price ÷ stated milligrams, converted to USD. Packs are priced on total milligrams. Listings sold per kit, per ml, as capsules or sprays, as blends, or without a stated mass are shown but not ranked.
Population
Active online research vendors only. Clinic, pharmacy and telehealth prices are excluded. Medians and the p25–p75 band are computed over comparable listings, one row per vendor product and size.
Independence. Ranking in this index: 0 paid placements.
PeptideBase accepts no payment for inclusion in this index.
PeptideBase takes no affiliate commission on vendor sales.
Ordering is by price, from scraped data.
Educational research tools — not medical advice.